Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Health Management Corp. (CNHC)
Dallas, TX, US
China Health Management Corp. is a firm primarily focused on hospital operation and administration within China. The company delivers an extensive range of healthcare services, covering clinical areas such as gynecology and obstetrics, pediatrics, dentistry, dermatology, pathology, eye and ear care (ophthalmology and otolaryngology), anesthesia, and hemodialysis. Its comprehensive offerings also include surgical procedures, emergency and intensive care, preventive medicine, pharmaceutical provision, psychological and general medical consultation, integrated Chinese and Western medical practices, and diagnostic services like medical examinations, imaging, and functional tests. In addition to direct patient care, it offers specialized hospital management services, such as commissioning and consultation. The company, which was established in 1996, adopted its current name in March 2006, transitioning from its former identity as Max Internet Communications, Inc. China Health Management Corp. is headquartered in Dallas, Texas.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -2.78% | +16.67% | +45.83% | +600.00% | +2.94% | -53.33% | -81.57% | +75.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Shell Companies: +20.6%+6.2% Q1'26: +16.1% (vs Q1'25)
-
EPS growth Shell Companies: -12.3%+90.0% ★
-
FCF margin FCF growth · Shell Companies: +8.7%-132.6% Q1'26: +137.2% (vs Q1'25)
-
EBIT margin Shell Companies: +0.0%+27.1% ★ Q1'26: +69.5% (vs Q1'25)
-
ROIC Shell Companies: +0.0%+5.3% ★ Q1'26: +21.6% (vs Q1'25)
-
Share dilution Shell Companies: -10.2%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×26.69× Q1'26: 11.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Charles Chen | Chief Medical Officer of Medical Department | — | male |
| Liang Xu | Head of Finance & Accounting and Administrative Director | — | male |
| Ni Wang Shu | Head Nurse of Patient Care Services Department | — | female |
| Rui Qu | Department Head of Physical Examination Department | — | male |
| Xu Mei | Chief Executive Officer, President & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CNHC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
